129 related articles for article (PubMed ID: 1403142)
21. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments.
Goldenberg DM; Wlodkowski TJ; Sharkey RM; Silberstein EB; Serafini AN; Garty II; Van Heertum RL; Higginbotham-Ford EA; Kotler JA; Balasubramanian N
J Nucl Med; 1993 Jan; 34(1):61-70. PubMed ID: 8418273
[TBL] [Abstract][Full Text] [Related]
22. [Immunoscintigraphy using radio-labeled monoclonal antibodies. Development of a method of cancer diagnosis and hopes for a new form of therapy].
Mach JP; Bischof-Delaloye A; Curchod S; Studer A; Grob JP; Volant JC; Mosimann F; Givel JC; Douglas P; Leyvraz S
Schweiz Med Wochenschr; 1987 Jul; 117(29):1076-86. PubMed ID: 3499666
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis of local recurrence of colorectal cancer, using PET and immunoscintigraphy by means of 131I or 111In anti-CEA monoclonal antibody].
Ito K; Nakata K; Watanabe T; Hibi K; Kasai Y; Akiyama S; Takagi H
Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):373-9. PubMed ID: 9101544
[TBL] [Abstract][Full Text] [Related]
24. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
[TBL] [Abstract][Full Text] [Related]
25. Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors.
Delaloye AB; Delaloye B; Buchegger F; Vogel CA; Gillet M; Mach JP; Smith A; Schubiger PA
J Nucl Med; 1997 Jun; 38(6):847-53. PubMed ID: 9189128
[TBL] [Abstract][Full Text] [Related]
26. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA 102: whole IgG versus F(ab')2 fragments].
Wada K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):266-73. PubMed ID: 1513308
[TBL] [Abstract][Full Text] [Related]
27. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies].
Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K
Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001
[TBL] [Abstract][Full Text] [Related]
28. [Immunoscintigraphic follow-up studies with the 99m-Tc marked monoclonal anti-CEA antibody BW 431/26].
Fritzsche H
Acta Med Austriaca; 1990; 17(2-3):44-6. PubMed ID: 2220267
[TBL] [Abstract][Full Text] [Related]
29. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
[TBL] [Abstract][Full Text] [Related]
30. [Localization of radiolabeled antibody to carcinoembryonic antigen in patients with gastrointestinal carcinoma].
Ohashi A
Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):297-306. PubMed ID: 3713682
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of anti-CEA antibody accumulation in human colorectal carcinomas.
Bares R; Fass J; Hauptmann S; Braun J; Grehl O; Reinartz R; Buell U; Schumpelick V; Mittermayer C
Nuklearmedizin; 1993 Apr; 32(2):65-72. PubMed ID: 8479932
[TBL] [Abstract][Full Text] [Related]
32. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer.
Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG
J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505
[TBL] [Abstract][Full Text] [Related]
33. 67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma.
Becker WS; Behr TM; Cumme F; Rössler W; Wendler J; Kern PM; Gramatzki M; Kalden JR; Goldenberg DM; Wolf FG
Cancer Res; 1995 Dec; 55(23 Suppl):5771s-5773s. PubMed ID: 7493344
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
35. [Immunoscintigraphy in stomach neoplasms with anti-CEA BW 431/26 monoclonal antibodies marked with Tc 99 m].
González P; Escobar MI; Csendes A; Lillo R; Fodor M; Guzmán G; Baum RP; Massardo T; Gaínza V; Otárola S
Rev Med Chil; 1991 May; 119(5):572-6. PubMed ID: 1844299
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of an anti-carcinoembryonic monoclonal antibody suitable for immunoscintigraphy.
Moraes DW; Lima EN; Prado IB; Carneiro CR
Braz J Med Biol Res; 1999 Aug; 32(8):967-74. PubMed ID: 10454758
[TBL] [Abstract][Full Text] [Related]
37. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
[TBL] [Abstract][Full Text] [Related]
38. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist].
Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH
Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823
[TBL] [Abstract][Full Text] [Related]
39. Comparison of gallium-67 versus indium-111 monoclonal antibody (96.5, ZME-018) in detection of human melanoma in athymic mice.
Chan SM; Hoffer PB; Maric N; Zoghbi SS; Kirkwood JM; Ernstoff MS; Duray PH; Gerich B
J Nucl Med; 1987 Sep; 28(9):1441-6. PubMed ID: 3476691
[TBL] [Abstract][Full Text] [Related]
40. Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis.
Corbisiero RM; Yamauchi DM; Williams LE; Esteban JM; Odom-Maryon T; Beatty JD
Cancer Res; 1991 Oct; 51(20):5704-11. PubMed ID: 1913688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
